| Name | Title | Contact Details |
|---|
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
Mintwave is a New York, NY-based company in the Business Services sector.
Managed Mobile Solutions is a Louisville, KY-based company in the Business Services sector.
Setpoint Systems Corporation is a Littleton, CO-based company in the Business Services sector.
Residential Real Estate Council is a professional network of over 30,000 residential real estate professionals in the U.S. and overseas that provides real estate agents with the tools, resources and strategies they need to help them guide buyers and se...